Physician profile
Matthew S Root
NPI 1043593098
$2,056.40
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,845 · 2020: $78.64 · 2021: $86.86 · 2022: $46.33.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $1,469.30 | 2019 | |
| Abbott Laboratories | $155.66 | 2019-2020 | |
| Boston Scientific Corporation | $86.86 | 2021 | |
| Nevro Corp. | $82.44 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $66.79 | 2019-2020 | |
| Flowonix Medical Incorporated | $66.00 | 2019-2020 | |
| Sentynl Therapeutics, INC. | $61.07 | 2019-2020 | |
| Stryker Corporation | $26.44 | 2019 | |
| Scilex Pharmaceuticals INC. | $24.28 | 2019 | |
| Collegium Pharmaceutical, INC. | $17.56 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Root listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.